SCHEMBL3045542

SCHEMBL3045542

CCCCCCCCCS(=O)(=O)NN

nearest known ligand 0.50

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CA2 P00918 6/20 0.50
FAAH O00519 2/20 0.50
RELA Q04206 4/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5448578 1.00 CA2 (0.50) CA2FAAHRELA
SCHEMBL27856585 1.00 CA2 (0.50) CA2FAAHRELA
SCHEMBL5452276 1.00 CA2 (0.50) CA2FAAHRELA
SCHEMBL5446492 1.00 CA2 (0.50) CA2FAAHRELA
SCHEMBL9154551 1.00 CA2 (0.50) CA2FAAHRELA
SCHEMBL5444476 1.00 CA2 (0.50) CA2FAAHRELA
SCHEMBL28333170 1.00 CA2 (0.50) CA2FAAHRELA
SCHEMBL476039 0.98 CA2 (0.46) CA2FAAHRELA
Ammonia Solution, Strong SCHEMBL28188858 0.95 CA2 (0.45) CA2FAAHRELA
SCHEMBL5446575 0.90

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130266533-A1 SULFONE POLYMER COMPOSITIONS GENZYME CORPORATION 2013-10-10 US claimed
EP-2131820-A1 SULFONE POLYMER COMPOSITIONS Genzyme Corporation (US) 2009-12-16 EP claimed
WO-2008109095-A1 SULFONE POLYMER COMPOSITIONS GENZYME CORPORATION (US) 2008-09-12 WO claimed
US-20130266533-A1 SULFONE POLYMER COMPOSITIONS GENZYME CORPORATION 2013-10-10 US disclosed
US-20100196305-A1 SULFONE POLYMER COMPOSITIONS GENZYME CORPORATION 2010-08-05 US disclosed
EP-2131820-A1 SULFONE POLYMER COMPOSITIONS Genzyme Corporation (US) 2009-12-16 EP disclosed
WO-2008109095-A1 SULFONE POLYMER COMPOSITIONS GENZYME CORPORATION (US) 2008-09-12 WO disclosed
US-20070155924-A1 Starter systems II COGNIS DEUTSCHLAND GMBH & CO. KG (DE) 2007-07-05 US disclosed
EP-1622945-A1 STARTER SYSTEMS II Cognis Deutschland GmbH & Co. KG (DE) 2006-02-08 EP disclosed
WO-2004099263-A1 STARTER SYSTEMS II COGNIS DEUTSCHLAND GMBH & CO. KG (DE) 2004-11-18 WO disclosed
CN-1362954-A Sulfamidohydroxamic acid metalloprotease inhibitor SEARLE & CO (US) 2002-08-07 CN disclosed
EP-0055087-B1 COMPOSITIONS AND METHODS FOR PRODUCING EXPANDED AND CURED POLYESTER RESIN UNIROYAL, INC. (US) 1986-05-07 EP disclosed
US-4525487-A FROM USATURATED POLYESTER SULFONYL HYDRAZIDE, PROMOTER, CATALYST, AND QATERNARY AMMONIUM SALT UNIROYAL, INC. (US) 1985-06-25 US disclosed
EP-0101197-A2 Method for preparing foam using cobalt/potassium promoters UNIROYAL, INC. (US) 1984-02-22 EP disclosed
US-4401771-A HYDROCARBYLSULFONYL HYDRAZIDE FOAMING AGENT UNIROYAL, INC. (US) 1983-08-30 US disclosed
EP-0055087-A1 Compositions and methods for producing expanded and cured polyester resin UNIROYAL, INC. (US) 1982-06-30 EP disclosed
US-4327196-A USING SULFONYL HYDRAZIDE BLOWING AGENTS, PEROXIDE CURING AGENTS FOR SIMULTANEOUS FOAMING AND CURING UNIROYAL, INC. (US) 1982-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100196305-A1 SULFONE POLYMER COMPOSITIONS SELE, MPST, PHOSPHO1 CA2 662/4885FAAH 2788/4885RELA 4615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.